Oxford Biomedica PLC Notification Of Major Interest In Shares (9291Z)
December 16 2014 - 10:50AM
UK Regulatory
TIDMOXB
RNS Number : 9291Z
Oxford Biomedica PLC
16 December 2014
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------------------------------------------
1. Identity of the issuer or the underlying OXFORD BIOMEDICA PLC
issuer
of existing shares to which voting rights
are
attached: (ii)
-------------------------------------------------- ----------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
--------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
----------------------------------------------------------------------------- -------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
----------------------------------------------------------------------------- -------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
----------------------------------------------------------------------------- -------
An event changing the breakdown of voting rights
----------------------------------------------------------------------------- -------
Other (please
specify):
------------------ --------------------------------------------------------- -------
3. Full name of person(s) subject VULPES LIFE SCIENCES FUND
to the VULPES TESTUDO FUND
notification obligation: (iii)
------------------------------------------ ------------------------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
------------------------------------------ ------------------------------------------
5. Date of the transaction and date 12 DECEMBER 2014
on
which the threshold is crossed
or
reached: (v)
------------------------------------------ ------------------------------------------
6. Date on which issuer notified: 15 DECEMBER 2014
------------------------------------------ ------------------------------------------
7. Threshold(s) that is/are crossed <18%
or
reached: (vi, vii)
------------------------------------------ ------------------------------------------
8. Notified details:
---------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
---------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- ------------------------------------ ----------------------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
------------- ---------------- ------------------ -------------- ------------------------- ---------------------------
Direct Direct (xi) Indirect Direct Indirect
(xii)
------------- ----- ------- ------ ----- --- -------------- -------------- --------- -------------- -----------
GB0006648157 533,250,100 533,250,100 447,452,767 447,452,767 17.44%
---------------- ------------------ -------------- -------------- --------- -------------- -----------
B: Qualifying Financial Instruments
---------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
---------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion Period rights that may rights
(xiv) be
acquired if the
instrument is
exercised/ converted.
---------------------- --------------- --------------------------------- ----------------------------- ----------------
C: Financial Instruments with similar economic effect to Qualifying
Financial Instruments (xv, xvi)
---------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
---------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting rights % of voting
financial price date (xvii) Conversion instrument refers rights (xix,
instrument period to xx)
(xviii)
--------------- -------------- ------------- ------------------- ----------------------------- -----------------------
Nominal Delta
--------------- -------------- ------------- ------------------- ----------------------------- ------------- --------
Total (A+B+C)
---------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
----------------------------------------------------------------- --------------------------------------------------------
447,452,767 17.44%
----------------------------------------------------------------- --------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
--------------------------------------------------------------------------------
Proxy Voting:
--------------------------------------------------------------------------------
10. Name of the proxy holder:
--------------------------------------------------- ---------------------------
11. Number of voting rights proxy holder will
cease
to hold:
--------------------------------------------------- ---------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
--------------------------------------------------- ---------------------------
13. Additional information:
---------------------------------------- --------------------------------------
14. Contact name: Tim Watts, Chief Financial Officer
Oxford BioMedica
---------------------------------------- --------------------------------------
15. Contact telephone number: +44 (0) 1865 783 000
---------------------------------------- --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCTFBITMBTBBII
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Apr 2024 to May 2024
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From May 2023 to May 2024